Author:
Tsakonas Georgios,Tadigotla Vasisht,Chakrabortty Sudipto K.,Stragliotto Giuseppe,Chan Dalin,Lewensohn Rolf,Yu Wei,Skog Johan K.,Hydbring Per,Ekman Simon
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference40 articles.
1. Current management of brain metastases, with a focus on systemic options;Langer;J. Clin. Oncol.,2005
2. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis;Sorensen;J. Clin. Oncol.,1988
3. Prognosis of patients treated for intracranial metastases with whole-brain irradiation;Sundstrom;Ann. Med.,1998
4. A phase II trial of bevazicumab in combination with first-line chemotherapy or second-line erlotinib in nonsquamous NSCLC patients with asymptomatic untreated brain metastases;Besse;Ann. Oncol.,2012
5. Gadgeel SM, Shaw A.T.,Govindan R., et al. Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 2016;Published online ahead of print at www.jco.org on October 3, 2016.